Cassandra Pardini, PharmD

The authors searched 4 international databases for studies reporting on myopericarditis in temporal relation to vaccination in the general population.

At the beginning of 2022, 25% of American adults were found to remain partially vaccinated or unvaccinated against COVID-19.

Pharmacotherapeutic issues associated with generic substitutions of antiseizure medications may not only be the result of the FDA’s bioequivalence standards.

The study authors focused on 4 pharmacologic classes: glucocorticoids, antiretroviral therapies, newer atypical antipsychotics, and immune checkpoint inhibitors.

Since patients with poor PS (≥2) were excluded from trials analyzing this new standard of care for mRCC treatment, the study aimed to assess the efficacy and safety of immune checkpoint combination therapy in this group of patients.

The real-world study compared the efficacy of neoadjuvant chemotherapy plus immunotherapy vs chemotherapy alone in patients with cT2-4bN0-3M0-1a pathological and imaging diagnosed MIBC.

The network meta-analysis aimed to compare various combinations of treatment options to determine the safest and most effective management strategy for mCSPC.

The study included a total of 183 patients with genitourinary cancers.

Patients with locally advanced or metastatic urothelial cancer that did not worsen during or following completion of first-line chemotherapy were included in the analysis.

The case-based study aimed to analyze the prescribing behaviors of community oncologists treating patients with aRCC.